|
The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. ---------- FTSE 100 winners ---------- Computacenter PLC, up 11% at 4,594.00p, raises outlook as hyperscaler demand boosts US trade Antofagasta PLC, up 3.6% at 3,654.50p, Citigroup raises its price target to 4,400p from 4,300p but BofA trims price target to 4,700p from 4,800p Glencore PLC, up 3.5% at 507.95p Anglo American PLC, up 3.0% at 3,482.00p, BofA ups price target to 3,900p from 3,800p Standard Chartered PLC, up 2.7% at 2,091.00p ---------- FTSE 100 losers ---------- AstraZeneca PLC, down 8.2% at 13,066.00p, cardiovascular drug Wainua fails test British American Tobacco PLC, down 2.4% at 4,501.50p, shares trade ex-dividend BAE Systems PLC, down 2.1% at 1,883.75p BP PLC, down 1.8% at 482.55p, dragged down by a slight drop in oil prices Coca-Cola Europacific Partners PLC, down 1.7% at 7,855.00p ---------- FTSE 250 winners ---------- Playtech PLC, up 17% at 373.30p, first-half trading ‘significantly’ ahead of expectations, ups guidance Elementis PLC, up 4.7% at 157.30p, Kepler Cheuvreux starts coverage with ’buy’, sets price target of 205p Bytes Technology Group PLC, up 4.6% at 412.20p, trades ‘well’ in the past four months Aston Martin Lagonda Global Holdings PLC, up 4.5% at 37.94p Pan African Resources PLC, up 4.4% at 94.28p ---------- FTSE 250 losers ---------- Zigup PLC, down 4.1% at 446.25p AO World PLC, down 2.6% at 92.05p, shares trade ex-dividend Sirius Real Estate Ltd, down 2.4% at 93.80p, shares trade ex-dividend Invesco Asia Dragon Trust PLC, down 2.0% at 488.75p, shares trade ex-dividend Chemring Group PLC, down 2.0% at 536.75p ---------- FTSE 100 & 250 movers in focus: ---------- Computacenter PLC, up 11% at 4,594.00 pence, 12-month range 2,092.00p-4,702.00p. Raises full-year guidance after stronger-than-expected second-quarter trading, driven by surging demand from hyperscaler customers in North America and continued AI-related projects in the UK. The technology services provider now expects adjusted pretax profit for the year to come in comfortably ahead of market expectations of £313.7 million, with first-half adjusted pretax profit set to be around double last year’s £81.5 million. It also says its committed product order backlog at the end of June was well above the £7.1 billion reported at the end of 2025. ---------- AstraZeneca PLC, down 8.2% at 13,066.00 pence, 12-month range 10,148.00p-15,732.00p. Sinks after saying cardiovascular drug Wainua failed to meet the primary endpoint in a phase III trial for patients with transthyretin-mediated amyloid cardiomyopathy. The drug, which AstraZeneca is developing with Ionis Pharmaceuticals, did not show a statistically significant benefit on mortality or cardiovascular clinical events compared with placebo, although the company says its safety profile remained consistent with previous studies and it will analyse the full data set with its partner. ---------- Playtech PLC, up 17% at 373.30 pence, 12-month range 210.00p-447.00p. Says first-half trading is significantly ahead of market expectations, driven by strong momentum in the Americas, and upgrades its full-year guidance. The Isle of Man-based gambling software firm expects adjusted Ebitda for the first half to exceed €155 million, reflecting particularly strong performance in the US through its partnership with Hard Rock Digital, alongside continued strength in Mexico, Colombia and certain European markets. While it expects second-half adjusted Ebitda to be lower as US revenue normalises, investment continues in Brazil and higher UK remote gaming duty takes effect, Playtech now forecasts full-year adjusted Ebitda of at least €270 million, above current analyst consensus of €219 million. The company will report interim results on September 10. CEO Mor Weizer says: ‘Playtech continues to further establish itself in regulated and regulating markets going into the second half of the year, and we are pleased with the progress towards our medium-term targets.’ ---------- Bytes Technology Group PLC, up 4.6% at 412.20 pence, 12-month range 248.60p-431.60p. Says it traded well in the four months to June 30, in line with guidance, delivering double-digit year-on-year growth in both gross invoiced income and gross profit. The software, security and cloud services provider adds that operating profit was broadly unchanged from a year earlier ahead of its annual general meeting. ---------- Centrica PLC, down 0.7% at 170.36 pence, 12-month range 152.45p-220.30p. The British Gas owner says the UK government has signed heads of terms for a 20-year regulated contract that will support the life extension of the Sizewell B nuclear power station from 2035 to 2055. The company, which holds a 20% stake in the 1.2-gigawatt plant, says Sizewell B will receive an inflation-linked contract-for-difference strike price of £70.50 per megawatt hour, based on 2025 prices, providing predictable revenues. Centrica says the agreement underpins a fair return on around £800 million of life extension investment, which it expects to fund through existing operating cash flows from its nuclear partnership with EDF Energy, without requiring additional equity. The company says the final contract with the UK government is expected to be completed later this year. ---------- Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
